Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3678394018 | Doxazosin (as doxazosin mesilate) 2 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3678395017 | Doxazosin (as doxazosin mesylate) 2 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3726098017 | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
56925701000001118 | Doxazosin 2mg tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing doxazosin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing doxazosin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Doxazosin mesilate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Doxazosin mesilate | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Doxazosin | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 2 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing doxazosin in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Doxazosin mesilate | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only doxazosin in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tablet.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Doxazosin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Doxazosin | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Doxazosin | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has specific active ingredient | Doxazosin mesilate | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has dispensed dose form | Tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Doxazosin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Doxazosin 2mg tablet - product | Is a | False | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Cascor 2mg tablets (Ranbaxy (UK) Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Cardura 2mg tablets (Viatris UK Healthcare Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Approved Prescription Services) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Viatris UK Healthcare Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Sandoz Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Sterwin Medicines) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Unichem Plc) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (A A H Pharmaceuticals Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (IVAX Pharmaceuticals UK Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Ranbaxy (UK) Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Accord Healthcare Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Cardura 2mg tablets (PI) (Waymade Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxadura 2mg tablets (Dexcel-Pharma Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Relonchem Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Almus Pharmaceutical Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets 28 tablet | Is pack of | False | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets 30 tablet | Is pack of | False | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Arrow Generics Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Cardura 2mg tablets (PI) (Dowelhurst Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Medihealth (Northern) Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Dexcel-Pharma Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Consilient Health Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Cardura 2mg tablets (Sigma Pharmaceuticals Plc) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets 14 tablet | Is pack of | False | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Sigma Pharmaceuticals Plc) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets 14 tablet | Has VMP | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets 28 tablet | Has VMP | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets 30 tablet | Has VMP | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Bristol Laboratories Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Cardura 2mg tablets (Lexon (UK) Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Cardura 2mg tablets (Mawdsley-Brooks & Company Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Sovereign Medical Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Cardura 2mg tablets (Necessity Supplies Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Phoenix Healthcare Distribution Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Fannin (UK) Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Medreich Plc) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Waymade Healthcare Plc) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (DE Pharmaceuticals) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Mawdsley-Brooks & Company Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Milpharm Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
Doxazosin 2mg tablets (Ennogen Pharma Ltd) | Is a | True | Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets